This Core will address (1) information management for clinical and physics projects, (2) treatment planning and delivery issues related to bi-institutional collaborative trials, and (3) statistical issues. The tasks will be coordinated by the Core Directors, Michael Gillin, Ph.D., and Beow Yeap, Sc.D., and the Co-Investigators. The management of this Core will be a team effort, with each investigator contributing within their area of specialization. The team will use two different information management systems for clinical studies. Team members at Massachusetts General Hospital (MGH) will operate the """"""""Trial DB"""""""" patient-specific non-DICOM information management system for registering and randomizing patients. Secondly, both institutions will use a database management system for DICOM-RT objects operated by the Image-guided Therapy QA Center (ITC) at Washington University (WU) in St. Louis. The second database system is necessary because Trial DB does not manage DICOM objects. Members of the team at M. D. Anderson Cancer Center (MDACC) will use a system called Evercore to manage DICOM and NON-DICOM databases for studies in physics (Projects 3 and 4). MGH and MDACC have substantial experience in cooperative group activities and will address treatment planning and delivery issues of relevance to proton therapy trials in a bi-institutional setting in a manner consistent with the high standards of established cooperative groups. Explicit issues addressed in this Core include proton beam calibration, treatment delivery quality assessment programs, CT-based treatment planning using both commercial and Monte Carlo approaches, and protocol compliance. Team members from MGH and MDACC agree to work with the Radiological Physics Center, which will provide an independent review of treatment planning and treatment delivery systems used in this program project. Our experience with trials in the bi-institutional settings should serve as the basis to define standards for the use of protons in multi-institutional trials. The knowledge gained will be communicated to cooperative groups for their consideration.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA021239-34
Application #
8736220
Study Section
Special Emphasis Panel (ZCA1-RPRB-J (M1))
Project Start
1997-04-01
Project End
2014-07-31
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
34
Fiscal Year
2013
Total Cost
$258,533
Indirect Cost
$48,664
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Pulsifer, Margaret B; Duncanson, Haley; Grieco, Julie et al. (2018) Cognitive and Adaptive Outcomes After Proton Radiation for Pediatric Patients With Brain Tumors. Int J Radiat Oncol Biol Phys 102:391-398
Liao, Zhongxing; Lee, J Jack; Komaki, Ritsuko et al. (2018) Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. J Clin Oncol 36:1813-1822
Jeter, Melenda D; Gomez, Daniel; Nguyen, Quynh-Nhu et al. (2018) Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A P Int J Radiat Oncol Biol Phys 100:730-737
Frank, Steven J; Blanchard, Pierre; Lee, J Jack et al. (2018) Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. Semin Radiat Oncol 28:108-113
Lin, Yu-Fen; Chen, Benjamin P; Li, Wende et al. (2018) The Relative Biological Effect of Spread-Out Bragg Peak Protons in Sensitive and Resistant Tumor Cells. Int J Part Ther 4:33-39
Ning, Matthew S; Tang, Linglong; Gomez, Daniel R et al. (2017) Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 99:70-79
Chang, Joe Y; Zhang, Wencheng; Komaki, Ritsuko et al. (2017) Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer. Radiother Oncol 122:274-280
Sanford, Nina N; Yeap, Beow Y; Larvie, Mykol et al. (2017) Prospective, Randomized Study of Radiation Dose Escalation With Combined Proton-Photon Therapy for Benign Meningiomas. Int J Radiat Oncol Biol Phys 99:787-796
Taylor, Paige A; Kry, Stephen F; Followill, David S (2017) Pencil Beam Algorithms Are Unsuitable for Proton Dose Calculations in Lung. Int J Radiat Oncol Biol Phys 99:750-756
Yock, Torunn I; Yeap, Beow Y; Ebb, David H et al. (2016) Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol 17:287-98

Showing the most recent 10 out of 260 publications